PR Newswire
LOS ANGELES
,
Dec. 30, 2020
/PRNewswire/ —
The Schall Law Firm
, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fortress Biotech, Inc. (“Fortress” or “the Company”) (NASDAQ:
FBIO
) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
10b
-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between
December 11, 2019
and
October 9, 2020
, inclusive (the ”Class Period”), are encouraged to contact the firm before
January 26, 2021
.
If you are a shareholder who suffered a loss,
click here to participate
.
We also encourage you to contact
Brian Schall
of the Schall Law Firm, 2049 Century Park East, Suite 2460,
Los Angeles, CA
90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at
www.schallfirm.com
, or by email at
[email protected]
.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Fortress’ majority-controlled subsidiary Avenue Therapeutics Inc. submitted a New Drug Application (“NDA”) for its IV Tramadol product in
December 2019
. In fact, IV Tramadol was not safe for use with its intended patients. Based on these safety problems, it was not likely that the FDA would approve the NDA for IV Tramadol. Based on this news, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Fortress, investors suffered damages.
Join the case
to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
SOURCE The Schall Law Firm
